TEMPOL-H: Clinical Trials

3 trials of TEMPOL-H, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 available. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow TEMPOL-H: new trials by email Literature Review of TEMPOL-H trials Research Report on TEMPOL-H

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
MBM-02 - Glioblastoma, Glioblastoma Multiforme
Phase 2UnknownMatrix Biomed, Inc.552021-06-012021-05-05
MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer
MBM-02 - Prostate Cancer Recurrent, Biochemical Recurrent Prostate Cancer
Phase 2UnknownMatrix Biomed, Inc.552021-05-302021-05-06
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
MBM-02 (Tempol) - Prostate Cancer
AvailableMatrix Biomed, Inc.2021-05-05

Conditions studied

Glioblastoma (1)  ·  Prostatic Neoplasms (1)

Sponsors

Matrix Biomed, Inc. (3)

Countries

United States (3)

Top investigators

Joseph Watson, M.D. (1)